'Give scientists enough freedom'Economic Times, India - 19 hours agoSpecific contracts will then be assigned to individual contract manufacturers and clinical research organisations. Scientists in the private sector have ...
Jubilant acquires DRAXIS for $225 mn - Business Standard
Jubilant acquires DRAXIS for $225 mnBusiness Standard, India - 3 hours ago... active pharmaceutical ingredients, generic dosage forms, drug discovery services, drug development services, chemistry services and clinical research ...
Neutropenia: Biosimilar Product from India Moves one Step Closer ... - ScienceBlog.com
Neutropenia: Biosimilar Product from India Moves one Step Closer ...ScienceBlog.com, CA - 8 hours agoWe are very confident that our joint clinical trials with Kwizda Pharma will demonstrate the quality of Neukine to the European authorities. ...
Manipal Cure and Care to Launch in Mumbai in May - Business Wire India (press release)
Manipal Cure and Care to Launch in Mumbai in MayBusiness Wire India (press release), India - 1 hour agoThis pioneering venture introduces to India the concept of holistic Health and Wellness care in a retail format, providing superior clinical services with ...
India a popular destination for clinical research - Sify
India a popular destination for clinical researchSify, India - Apr 3, 2008New Delhi: India has emerged as a popular destination for clinical research, overtaking China, and is cheaper too, says a Planning Commission report. ...
Budget Speak 2008-09 - Express Pharma
Express PharmaBudget Speak 2008-09Express Pharma, India - 6 hours agoThe FM has supported R&D for companies engaged in research which should benefit the clinical trial houses. This should continue to support India's case to ...Logistics issues in Indian pharmaceutical industry Express PharmaUnclogging the pharma logistics chain Express Pharmaall 3 news articles
SIRO gets IT solutions from Sun and Oracle - Express Pharma
SIRO gets IT solutions from Sun and OracleExpress Pharma, India - 6 hours ago... Oracle India "SIRO's new IT infrastructure with OLSA provides them with a greater competitive advantage in providing clinical research services to the ...
The Glenmark benchmark - Express Pharma
Express PharmaThe Glenmark benchmarkExpress Pharma, India - 6 hours ago"In the NCEs segment, three leads are in phase II, two are entering phase I shortly and one is in pre-clinical stage. Whereas, in the biologics research ...
India has challenges for Thermofisher Scientific - Express Pharma
Express PharmaIndia has challenges for Thermofisher ScientificExpress Pharma, India - 6 hours agoSpecifically in India, the primary LIMS market is entire value chain of pharmaceuticals and in particular CROs or (Contract Research Organisations). ...
Attracting pharmaceutical investment to South Africa - Moneyweb
Attracting pharmaceutical investment to South AfricaMoneyweb, South Africa - 37 minutes agoSA was in the lead just five years ago but now clinical trial development is growing much faster in India and China. Cross cutting policy on innovation ...

